Clinical Trial Update: Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Fluorometholone for Dry Eye Disease (keratoconjunctivitis sicca) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Fluorometholone (fluorometholone)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Dry Eye | Phase 3 | Status: COMPLETED